
Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
March 13, 2023

Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
June 02, 2022

Specifica is pleased to announce the United States Patent and Trademark Office has granted two patents to Specifica for its innovative Generation 3 Antibody Discovery Platform
March 10, 2022

Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications
January 28, 2022

Welcome to AbXtract
December 02, 2021

OpenEye Scientific and Specifica Partner to Launch Orion® Antibody Discovery Suite incorporating AbXtract™
December 02, 2021

Specifica CTO, Sara D’Angelo, gives a tour of Specifica’s new facilities.
July 21, 2021

Specifica CSO, Andrew Bradbury, participates in Covid19 Antibody Roundtable Discussion
April 21, 2021

Specifica Delivers Antibody Platform to UCB to Speed up Development of New Therapeutics
December 01, 2020

Specifica Partners With Scholar Rock to Design and Create Antibody Display Library for Therapeutic Biologic Discovery
August 05, 2020